Press release
Blood Cancer Drugs Market Estimated at USD 55.6 Billion by 2025 - Major Key Player include Johnson & Johnson Inc., Amgen Inc., Bayer AG., Pfizer Inc., Eli Lily & Co., AstraZeneca, AbbVie Inc., Roche Holding AG, Celgene Corporation, Merck and Company
Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/global-blood-cancer-drugs-market/request-for-free-sample
Most of the blood cancers start in the bone marrow, where blood is produced. In blood cancer the growth of normal blood cells is dislodged by the uncontrollable growth of abnormal blood cells. These cancerous cells prevent the blood from performing many of its functions. Hence, the existing treatments of blood cancer are being the foundation for developing the new drugs.
The global blood cancer drugs market is segmented into blood cancer type, drugs and treatment approaches. On the basis of blood cancer type, the global blood cancer drugs market is segmented into leukemia, lymphoma and myeloma. The lymphoma segment is expected to drive the majority market of blood cancer drugs followed by leukemia. The global market of this segment is primarily driven by the increasing prevalence of lymphoma, and presence of effective treatments in the market. On the basis of drugs, the global blood cancer drugs market is further categorized into Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), and Others. This continuous innovation for treating various sub-types of blood cancers has led to the development of novel types of treatments. For instance, the combination of Revlimid and Velcade has emerged as the preferential drugs in trials for treating multiple myeloma.
Some of the key players in the global market include:
Johnson & Johnson Inc.
Amgen Inc.
Bayer AG.
Pfizer, Inc.
AbbVie Inc.
Roche Holding AG.
Celgene Corporation
AstraZeneca
Novartis AG
GlaxoSmithKline PLC
Merck & Co., Inc.
Eli Lily & Co.
Make an inquiry for purchasing this report @ https://www.polarismarketresearch.com/industry-analysis/global-blood-cancer-drugs-market/inquire-before-buying
On the basis of treatment approaches the global blood cancer drugs market is further segmented into Chemotherapeutic, mAbs/Targeted Therapies, and Immunotherapeutic. Due to availability of variety of chemotherapeutic agent in the market chemotherapeutic drugs are expected to hold the higher share in blood cancer drugs market. Moreover, their effectiveness for the treatment of blood cancer and increasing number of cancer patients globally has garnered more demand for chemotherapeutic drugs throughout the world.
Geographically, the global blood cancer drugs market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America dominates the blood cancer drugs market which is followed by Europe and Asia Pacific. Favorable reimbursement policies, surge in R&D investments of various companies, as well as the increase in the number of blood cancer treatments are some of the major factors responsible for the growth of North America’s blood cancer drugs market. Moreover, Asia-Pacific region has been identified as the lucrative market for the for blood cancer drugs due to increasing awareness of the use of these drugs, increased healthcare expenditure, and rising per capita disposable income. These are some of the major factors which are influencing the growth of the blood cancer drugs in Asia-pacific region.
Browse Complete Report Summary @ global blood cancer drugs market
Key Findings from the study suggest blood cancer drugs in the market are much innovative and manufacturers are progressively concentrating on innovation of combination drugs. Companies are in a stage of development of new drugs in order to provide novel treatments for blood cancer. The immunotherapy segment is anticipated to grow at a high growth rate over the forecast period. The growth of this segment is primarily driven by increased awareness for its use as an alternative and effective treatment for blood cancer. North America is presumed to dominate the global blood cancer drugs market over the forecast period. Asia Pacific region which shows signs of high growth potential owing to the booming economies of India, and China.
Key questions answered by the report
• What is the current market size and forecasts of global blood cancer drugs market?
• What is the market opportunity for the blood cancer treatment market?
• How big is the market size for treating subtypes of blood cancer market?
• How much will the North America blood cancer drugs market be worth by 2025?
• How big is the market size of chemotherapeutic treatment approach globally?
About us Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
We mainly focus on aiding our customers with substantial competitive intelligence, helping them to secure a competitive advantage in the market and accomplish sustainable growth in different market domains. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Through dedicated qualitative and quantitative primary and secondary market research and consulting assignments, we adeptly formulate competitive strategies to address business challenges for our clients through analyzing market trends and emerging technologies.
Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Blood Cancer Drugs Market Estimated at USD 55.6 Billion by 2025 - Major Key Player include Johnson & Johnson Inc., Amgen Inc., Bayer AG., Pfizer Inc., Eli Lily & Co., AstraZeneca, AbbVie Inc., Roche Holding AG, Celgene Corporation, Merck and Company here
News-ID: 1293251 • Views: …
More Releases from Polaris Market Research & Consulting
Cooling Fabrics Market Is Expected to Reach US$ 4.66 Billion by 2032, at a CAGR …
𝑻𝒉𝒆 𝒈𝒍𝒐𝒃𝒂𝒍 𝑪𝒐𝒐𝒍𝒊𝒏𝒈 𝑭𝒂𝒃𝒓𝒊𝒄𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 𝒘𝒂𝒔 𝒆𝒔𝒕𝒆𝒆𝒎𝒆𝒅 𝒂𝒕 𝑼𝑺𝑫 2.42 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 2023. 𝑳𝒐𝒐𝒌𝒊𝒏𝒈 𝒇𝒐𝒓𝒘𝒂𝒓𝒅, 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕 𝒊𝒔 𝒂𝒏𝒕𝒊𝒄𝒊𝒑𝒂𝒕𝒆𝒅 𝒕𝒐 𝒈𝒓𝒐𝒘 𝒕𝒐 𝑼𝑺𝑫 4.66 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒃𝒚 2032, 𝒆𝒙𝒉𝒊𝒃𝒊𝒕𝒊𝒏𝒈 𝒂 𝒄𝒐𝒎𝒑𝒐𝒖𝒏𝒅 𝒂𝒏𝒏𝒖𝒂𝒍 𝒈𝒓𝒐𝒘𝒕𝒉 𝒓𝒂𝒕𝒆 (𝑪𝑨𝑮𝑹) 𝒐𝒇 7.70% 𝒐𝒗𝒆𝒓 𝒕𝒉𝒆 𝒇𝒐𝒓𝒆𝒄𝒂𝒔𝒕 𝒑𝒆𝒓𝒊𝒐𝒅 𝒇𝒓𝒐𝒎 2024 𝒕𝒐 2032. 𝑻𝒉𝒆 𝒎𝒂𝒊𝒏 𝒇𝒂𝒄𝒕𝒐𝒓𝒔 𝒅𝒓𝒊𝒗𝒊𝒏𝒈 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕 𝒈𝒓𝒐𝒘𝒕𝒉 𝒂𝒓𝒆 𝒓𝒊𝒔𝒊𝒏𝒈 𝒅𝒊𝒔𝒑𝒐𝒔𝒂𝒃𝒍𝒆 𝒊𝒏𝒄𝒐𝒎𝒆 𝒂𝒏𝒅 𝒑𝒆𝒓 𝒄𝒂𝒑𝒊𝒕𝒂 𝒔𝒑𝒆𝒏𝒅𝒊𝒏𝒈, 𝒂𝒔 𝒘𝒆𝒍𝒍 𝒂𝒔 𝒂 𝒓𝒊𝒔𝒆 𝒊𝒏 𝒕𝒉𝒆 𝒅𝒆𝒎𝒂𝒏𝒅 𝒇𝒐𝒓 𝒔𝒑𝒐𝒓𝒕𝒔 𝒂𝒏𝒅…
Connected Medical Devices Market is projected to grow to US$ 190.63 Billion by 2 …
The global Connected Medical Devices Market was valued at USD 49.57 billion in 2022. Looking forward, the market is projected to grow to USD 190.63 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.4% over the forecast period from 2023 to 2032.
The rising aging population and the expansion of telehealth services are the primary factors propelling the market forward. Besides, the growing prevalence of chronic diseases…
Surgical Blade Market is expected to reach US$ 228.57 Million by 2032 | Data by …
According to a new market research report published by Polaris Market Research, the global Surgical Blade Market is expected to grow at a CAGR of 5.0% from 2023 to 2032. Its examination of technological progressions and developments in the industry and their influence on market attendance is anticipated to drive market expansion.
The global market was valued at USD 140.59 million in 2022 to USD 228.57 million by 2032, disclosing…
Fructooligosaccharides Market to Grow at CAGR of 8.50% Reaching USD 5.71 Billion …
𝐅𝐫𝐮𝐜𝐭𝐨𝐨𝐥𝐢𝐠𝐨𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
Continuing research into the health benefits of FOS and inventive commodity advancement has the possibility of capitulating new FOS-dependent commodities with improved functionality, which is pushing the market growth. Our thorough analysis of the Fructooligosaccharides Market covers the industry size, share, recent developments, and top trends. Besides, we have in-depth examined all the major regions and segments.
𝐓𝐡𝐞 𝐅𝐫𝐮𝐜𝐭𝐨𝐨𝐥𝐢𝐠𝐨𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞
• Market Size: The global market for fructooligosaccharides was valued…
More Releases for North
North America Epoxy Composites Market
North America Epoxy Composites Market, By Type (Glass Fiber, Cotton Fiber, Paper Fiber), Resin Type (Epoxy Resin, Phenolic Resin, Melamine Resin), Manufacturing Process (Layup Process, Compression Molding Process, Resin Injection Molding Process, Resin Transfer Molding Process, Filament Winding Process, Pultrusion Process), End User (Wind Energy, Aerospace and Defense, Sporting Goods, Automotive and Transportation, Electrical and Electronics, Pipe and Tank, Marine, Others), Country (U.S., Mexico, Canada) Industry Trends and Forecast to…
North America Drone Simulator industry report - North America Drone Simulator Ma …
The drone simulator market in North America is expected to reach US$ 535.17 million by 2028 from US$ 251.38 million in 2021; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028.
The latest North America Drone Simulator Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis…
UberJets Helping People Get North!
In 2022 consumers have the freedom to purchase, order, or reserve, practically anything with a click of a button. Buying has never been more transparent through the utilization of mobile app technology. Typically, users can perform tasks such as book a hotel or purchase game tickets all from an app; so it only makes sense that one can order a private aircraft to get to anywhere, and anytime using the…
North America Apnea Monitors Market : North America Opportunity Analysis and Ind …
CRIFAX has recently announced its latest research report on 'North America Apnea Monitors Market, 2020-2028' to its database of market research collaterals consisting of overall market scenario with prevalent and future growth prospects, among other growth strategies used by key players to stay ahead of the game. Additionally, recent trends, mergers and acquisitions, region-wise growth analysis along with challenges that are affecting the growth of the market are also stated…
North America Footwear Market -Consumers In North America Are More Inclined Towa …
In the last couple of years, North America has emerged at the forefront of the fashion and sports apparel industry. Not only has easy and uninterrupted internet access bolstered consumer awareness regarding the latest buzz in the fashion scenario, but it has also helped them shop for the products they want with a simple touch of their fingers on their smartphones or tablets. The developed countries in the region such…
Electrical Fuses Market: Production Enterprise To Become Main Application Phase …
The North America electrical fuses market is likely to witness the advent of more compact and slimmer electronics with leading players vying to cater to ever-changing consumer preferences. The development of the latest technologies and innovation have thus emerged as the most defining trends in the market. The electrical fuses market in North America is primarily driven by the rising demand for electricity and efficient power delivery systems. Besides this,…
